Losartan
Cozaar (losartan) is a small molecule pharmaceutical. Losartan was first approved as Cozaar on 1995-04-14. It is used to treat diabetic nephropathies, heart failure, hypertension, left ventricular dysfunction, and left ventricular hypertrophy in the USA. The pharmaceutical is active against type-1 angiotensin II receptor. In addition, it is known to target cytochrome P450 2C9.
| Trade Name | Cozaar |
|---|---|
| Common Name | Losartan |
| Indication | diabetic nephropathies, heart failure, hypertension, left ventricular dysfunction, left ventricular hypertrophy |
| Drug Class | Angiotensin II receptor antagonists |
